CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | Weill David Director | Purchase | +1,336 | $81.63 | $109K | 16,392 |
| 2026-05-20 | Weill David Director | Grant or award | +2,922 | 15,056 | ||
| 2026-03-04 | Weill David Director | Option exercise | +3,571 | $14.20 | $51K | 15,705 |
| 2026-03-04 | Weill David Director | Sale | −3,571 | $146.82 | $524K | 12,134 |
| 2026-03-04 | Weill David Director | Option exercise · Stock Option (Right to Buy) | −3,571 | 1,429 | ||
| 2025-12-03 | Weill David Director | Option exercise | +5,000 | $14.20 | $71K | 17,134 |
| 2025-12-03 | Weill David Director | Sale | −5,000 | $138.64 | $693K | 12,134 |
| 2025-12-03 | Weill David Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 5,000 | ||
| 2025-05-23 | Weill David Director | Sale | −732 | $123.88 | $91K | 12,134 |
| 2025-05-22 | Weill David Director | Grant or award | +2,134 | 12,866 | ||
| 2024-05-29 | Weill David Director | Sale | −1,193 | $141.65 | $169K | 10,732 |
| 2024-05-23 | Weill David Director | Grant or award | +732 | 11,925 | ||
| 2024-05-23 | Weill David Director | Grant or award · Stock Option (Right to Buy) | +1,154 | 1,154 | ||
| 2024-05-10 | Weill David Director | Sale | −2,500 | $129.82 | $325K | 11,193 |
| 2023-08-29 | Weill David Director | Purchase | +2,500 | $62.00 | $155K | 13,693 |
| 2023-05-25 | Weill David Director | Grant or award | +1,193 | 11,193 | ||
| 2023-05-25 | Weill David Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-02-27 | Weill David Director | Option exercise | +5,934 | $14.20 | $84K | 15,934 |
| 2023-02-27 | Weill David Director | Sale | −964 | $77.64 | $75K | 14,970 |
| 2023-02-27 | Weill David Director | Sale | −4,970 | $76.51 | $380K | 10,000 |
Page 1 of 2 · 24 trades